HCT — Holista Colltech Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$2.79m
- AU$2.88m
- AU$5.95m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.47 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | -1121.26% | ||
| Operating Margin | -82.17% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 7.27 | 7.13 | 8.03 | 8.24 | 5.95 | n/a | n/a | -5.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Holista CollTech Ltd is a research-driven biotech company. The Company is focused on researching, developing, manufacturing, and marketing health-style products. The Company's segments include Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate. The Supplements segment is involved in the manufacture and wholesale distribution of dietary supplements. The Ovine collagen segment is involved in the manufacture and distribution of cosmetic-grade collagen. The Food ingredients segment is involved in the manufacture and wholesale distribution of healthy food ingredients. The Infection control Solutions segment is involved in the infection control solutions. The Company’s products include Natshield Spray, Natshield Balm, and Natshield Wipes. Its all-natural products can be used as sanitizers, nasal balms, and as a consumable in the M3 system, which is developed to disinfect quarantine centers, offices, homes, and cars.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 18th, 2000
- Public Since
- February 26th, 2004
- No. of Employees
- 3
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 278,800,067
- Address
- 283 Rokeby Rd, SUBIACO, 6008
- Web
- https://www.holistaco.com/
- Phone
- +61 861413500
- Auditors
- Stantons International Audit and Consulting PTY Ltd
Upcoming Events for HCT
Half Year 2024 Holista CollTech Ltd Earnings Release
Similar to HCT
Actinogen Medical
Australian Stock Exchange - SEATS
Adalta
Australian Stock Exchange - SEATS
Algorae Pharmaceuticals
Australian Stock Exchange - SEATS
Alterity Therapeutics
Australian Stock Exchange - SEATS
Amplia Therapeutics
Australian Stock Exchange - SEATS
FAQ
What is the Holista Colltech share price?
As of Today at 19:10 UTC, shares in Holista Colltech are trading at AU$0.01. This share price information is delayed by 15 minutes.
How has the Holista Colltech share price performed this year?
Shares in Holista Colltech last closed at AU$0.01 and the price had moved by -47.37% over the past 365 days. In terms of relative price strength the Holista Colltech share price has underperformed the ASX All Ordinaries Index by -50.98% over the past year.
What are the analyst and broker recommendations for Holista Colltech?
There is no consensus recommendation for this security.
What is the Holista Colltech dividend yield?
Holista Colltech does not currently pay a dividend.
Does Holista Colltech pay a dividend?
Holista Colltech does not currently pay a dividend.
When does Holista Colltech next pay dividends?
Holista Colltech does not currently pay a dividend.
How do I buy Holista Colltech shares?
To buy shares in Holista Colltech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Holista Colltech?
As of the previous close price of AU$0.01, shares in Holista Colltech had a market capitalisation of AU$2.79m.
Where are Holista Colltech shares listed?
Here are the trading details for Holista Colltech:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: HCT
What kind of share is Holista Colltech?
Based on an overall assessment of its quality, value and momentum Holista Colltech is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Holista Colltech share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Holista Colltech share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Holista Colltech. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -18.77%.
As of the last closing price of AU$0.01, shares in Holista Colltech were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Holista Colltech PE Ratio?
The Holista Colltech PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Holista Colltech?
Holista Colltech's management team is headed by:
- M. Rajendran Marnickavasagar - CHM
- Hon Khien Kong - CFO
- Jay Stephenson - SEC
- Walter Joseph - NED
- Loren King - NED